Bentham is offering subject-based scholarly content collections which are tailored to meet specific research needs. Researchers can access related articles from current and back volumes by purchasing access to these collections. Subscribers will also have access to new articles as soon as they are published and added to these collections. With new articles being added to these collections on a daily basis, the collections serve as an ideal tool to keep researchers updated with new developments in the respective fields.
Journal: Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Volume: 2 Issue: 1 Year: 2015 Page: 52-55 Author(s): Hakan S. Sayiner,Birgül Tepe,Halil ErdoÄdu,M. Ãzgür Ãevik
Journal: Current Signal Transduction Therapy Volume: 10 Issue: 1 Year: 2015 Page: 31-35 Author(s): Xianqi Feng,Ling Zhang,Shumin Nie,Zhan Su,Xue Shi,Yan Gao,Xiangyun Chen,Wenyuan Niu,Zhongguang Cui,Hongguo Zhao,Fanjun Meng,Chunting Zhao
Journal: Current Cancer Drug Targets Volume: 15 Issue: 1 Year: 2015 Page: 53-70 Author(s): Xin Li,Xin A. Zhang,Wei Xie,Xiaoqing Li,Shiang Huang
Journal: Clinical Cancer Drugs Volume: 2 Issue: 2 Year: 2015 Page: 100-111 Author(s): Benny Johnson, Daruka Mahadevan
Journal: Anti-Cancer Agents in Medicinal Chemistry Volume: 15 Issue: 3 Year: 2015 Page: 298-306 Author(s): Long Ma,Aipo Diao
Journal: Current Drug Targets Volume: 16 Issue: 10 Year: 2015 Page: 1142-1159 Author(s): Salvatore Gizzo,Michela Quaranta,Giovanni Battista Nardelli,Marco Noventa
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets Volume: 15 Issue: 2 Year: 2015 Page: 88-96 Author(s): Atsuko Deguchi
Journal: Current Drug Targets Volume: 16 Issue: 10 Year: 2015 Page: 1107-1132 Author(s): Zhao Zhong Chong
Journal: Current Pharmaceutical Design Volume: 21 Issue: 1 Year: 2015 Page: 2147-2166 Author(s): Magdalena Kusaczuk, Marek Bartoszewicz, Marzanna Cechowska-Pasko
Journal: Current Pharmaceutical Design Volume: 21 Issue: 10 Year: 2015 Page: 1292-1300 Author(s): Ping Yang,Zihe Huo,Huaidong Liao,Quansheng Zhou
Previous Next